Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3744508

COc1ccc(S(=O)(=O)n2c(C)c(CC(=O)N3CCCNCC3)c3ccccc32)c2ccccc12.O=C(O)C(F)(F)F

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AVPR1B P47901 8/20 0.63
OXTR P30559 1/20 0.63
HTR6 P50406 3/20 0.49
KCNH2 Q12809 1/20 0.49
ALDH1A1 P00352 3/20 0.42
TSHR P16473 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
PKM P14618 1/20 0.37
HTR2C P28335 1/20 0.37
NPC1 O15118 1/20 0.36
BDKRB2 P30411 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3749338 0.87 AVPR1B (0.63) AVPR1BOXTRHTR6KCNH2ALDH1A1
Trifluoroacetic Acid SCHEMBL3752788 0.79 AVPR1B (0.54) AVPR1BOXTRHTR6KCNH2
Trifluoroacetic Acid SCHEMBL3750891 0.76 HTR6 (0.50) AVPR1BHTR6ALDH1A1TSHRSMN1; SMN2
Trifluoroacetic Acid SCHEMBL3752822 0.74 AVPR1B (0.52) AVPR1BOXTRHTR6KCNH2ALDH1A1
Trifluoroacetic Acid SCHEMBL3752797 0.73 AVPR1B (0.52) AVPR1BOXTRHTR6KCNH2HTT
Trifluoroacetic Acid SCHEMBL3755402 0.73 AVPR1B (0.53) AVPR1BOXTRHTR6KCNH2ALDH1A1
Trifluoroacetic Acid SCHEMBL3744543 0.72 HTR6 (0.47) AVPR1BOXTRHTR6KCNH2PKM
SCHEMBL3754751 0.69 HTR6 (0.75) AVPR1BOXTRHTR6KCNH2ALDH1A1
SCHEMBL3756866 0.67 AVPR1B (0.67) AVPR1BHTR6KCNH2ALDH1A1TSHR
SCHEMBL3751705 0.67 HTR6 (0.56) AVPR1BHTR6KCNH2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838518-B2 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders N.V. ORGANON (NL) 2010-11-23 US disclosed
EP-1476151-B1 1-ARYLSULFONYL-3-SUBSTITUED INDOLE AND INDOLINE DERIVATES USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ORGANON NV (NL) 2008-07-16 EP disclosed
US-20050154023-A1 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders MERCK SHARP & DOHME B.V. (NL) 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050154023-A1 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders TPH1, HTR1A, HTR1D AVPR1B 966/4885OXTR 1264/4885HTR6 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.